Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Pedestrian Injured in Crash at Roseville Road and Longview Drive


Man Injured in Hit and Run Accident in North Highlands

North Highlands, CA (April 3, 2020) – A pedestrian was injured in a hit and run crash in North Highlands. The accident occurred on the evening of April 3 at Roseville Road and Longview Drive.

A man was hit by a vehicle at the intersection for unknown reasons. Paramedics found the man lying on the side of the road. The victim was taken to a local hospital with unknown injuries. The driver fled the accident scene. 

#North Highlands

#95660


October 29, 2019

3 Killed in Crash at Brookside Drive and Giant Road

Amtrak Train, Car Collide in Fatal Richmond Accident...


October 17, 2019

Truck Driver Burned in Crash on Interstate 10 Near Cottonwood Springs Road

Victim Taken to Burn Center in Indio Accident Indio, CA (October 16, 2019) – ...


May 6, 2020

4 Killed in Crash at San Pasqual Valley Road and Oak Hill Drive

2 Adults, 2 Children Hit by Car in Fatal Escondido Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.